AC
AMRX icon

AXQ Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

AXQ Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,254
Closed -$233K – 717
2025
Q3 		$233K Buy
23,254
+6,675
+40% +$59.9K 0.09% 405
2025
Q2 		$134K Sell
16,579
-1,720
-9% -$13K 0.04% 496
2025
Q1 		$153K Buy
+18,299
New +$153K 0.06% 423

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

AXQ Capital's AMRX Position: Q4 2025 in Review

AXQ Capital sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 23,254 shares — an estimated $233K sold.

AXQ Capital first reported a position in AMRX in Q1 2025 and held it in 3 quarters. The position peaked at $233K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • AXQ Capital reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • AXQ Capital sold 23,254 Amneal Pharmaceuticals shares in Q4 2025, an estimated $233K.
  • AXQ Capital first reported a position in Amneal Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • AXQ Capital's Amneal Pharmaceuticals position peaked at $233K in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.